| 138 | |
| Summary | Gut microbes (species: Enterococcus faecalis) increase Levodopa's toxicity. |
| Gut | |
| Levodopa (PubChem CID: 6047) | |
| Enterococcus faecalis (Tax ID: 1351) | |
| 31196984 | |
| increase toxicity | |
| Levodopa, antiparkinson's drug, needs to be activated to dopamine after crossing the blood-brain barrier peripheral conversion to dopamine results in many side effecs. The gut microbiota mainly Enterococcus faecalis can metabolize levodopa peripherally. Enterococcus faecalis metabolizes levodopa by a pyridoxal phosphate-dependent tyrosine decarboxylase to dopamine. |
Browse Drug-Microbiome Relationship
Home